10
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Endothelin-1 Produces Heterogeneous Regional Haemodynamic Effects in Conscious Rabbits

, &
Pages 145-169 | Received 08 Mar 1995, Accepted 25 Jul 1995, Published online: 03 Jul 2009

References

  • Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415
  • Masaki T. The discovery, the present state, and the future prospects of endothelin. J Cardicvasc Pharmacol 1989; 13(Suppl. 5)S1–S1
  • Han S. P., Trapani A. J., Fok K. F., Westfall T. C., Knuepfer M. M. A comparison of the hemodynamic effects of endothelin-1 and sarafotoxin S6b in conscious rats. J Pharmacol Exp Ther 1991; 256: 183–188
  • Hof R. P., Hof A., Takiguchi Y. Massive regional differences in the vascular effects of endothelin. J Hypertens 1989; 7(Suppl 6)S274–S274
  • Lüscher T. F., Oemar B. S., Boulanger C. M., Hahn A. W.A. Molecular and cellular biology of endothelin and its receptors: part 1. J Hypertens 1993; 11: 7–11
  • Seo B., Oemar B. S., Siebenmann R., Von-Segesser L., Lüscher T. F. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89: 1203–1208
  • Simonson M. S., Dunn M. J. Endothelin: pathways in transmembrane signalling. Hypertension 1990; 15(Suppl.I)15–112
  • Suzuki Y., Tanoi C., Shibuya M., Sugita K., Masuzawa-Ito K., Asano M. Different utilization of Ca2+ in the contractile action of endothelin-1 on cerebral, coronary and mesenteric arteries of the dog. Eur J Pharmacol 1992; 219: 401–408
  • Douglas S. A., Elliott J. D., Ohlstein E. H. Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses. Eur J Pharmacol 1992; 221: 315–324
  • Moritoki H., Miyano H., Takeuchi S., Yamaguchi M., Hisayama T., Kondoh W. Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation. Br J Pharmacol 1993; 108: 1125–1130
  • de-Nucci G., Thomas R., D'Orléans-Juste P., Antunes E., Walder C., Warner T. D., Vane J. R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797–9800
  • Remuzzi G., Benigni A. Endothelins in the control of cardiovascular and renal function. Lancet 1993; 342: 589–593
  • Vatner S. F., Franklin D., Braunwald E. Effects of anesthesia and sleep on circulatory response to carotid sinus nerve stimulation. Am J Physiol 1971; 220: 1249–1255
  • Coughlan M. G., Flynn N. M., Kenny D., Warltier D. C., Kampine J. P. Differential relaxant effect of high concentrations of intravenous anesthetics on endothelin-constricted proximal and distal canine coronary arteries. Anesth Analg 1992; 74: 378–383
  • Minson R. B., McRitchie R. J., Chalmers J. P. Effects of neuropeptide Y on the heart and circulation of the conscious rabbit. J Cardiovasc Pharmacol 1989; 14: 699–706
  • Minson R. B., McRitchie R. J., Chalmers J. P. Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit. J Auton Nerv Syst 1989; 27: 139–146
  • Roberts-Thomson P., McRitchie R. J., Chalmers J. P. Effects of endothelin-1 on arterial pressure and myocardial contractility in the conscious normotensive rabbit. Clin Exp Pharmacol Physiol 1991; 18: 315–318
  • Houck P. C., Fiksen-Olsen M. J., Britton S. L., Romero J. C. Role of angiotensin and vasopressin on blood pressure of ganglionic blocked dogs. Am J Physiol 1983; 244: H115–H120
  • Holtz J., Förstermann U., Giesler P. M., Bassenge E. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. J Cardiovasc Pharmacol 1984; 6: 1161–1169
  • Elliott J. M., West M. J., Chalmers J. P. Effects of vasopressin on heart rate in conscious rabbits. J Cardiovasc Pharmacol 1985; 7: 6–11
  • Du Z. Y., Dusting G. J., Woodman O. L. Haemodynamic responses to N-nitro-1-arginine in conscious rabbits. Clin Exp Pharmacol Physiol 1991; 18: 371–374
  • Clifton G. D., Booth D. C., Hobbs S., Boucher B. A., Foster T. S., McAllister R. G., DeMaria A. N. Negative inotropic effect of intravenous nifedipine in coronary artery disease: relation to plasma levels. Am Heart J 1990; 119: 283–290
  • Aylward P. E., McRitchie R. J., Chalmers J. P. Relative roles of vagal and sympathetic effector mechanisms in the baroreflex control of myocardial contractility in conscious rabbits. Pflügers Arch 1985; 403: 21–27
  • Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1–9
  • The GLM procedure. SAS/STAT User's Guide Release 6.03 SAS Institute Inc. Cary 1988; 593–599
  • Ludbrook J. On making multiple comparisons in clinical and experimental pharmacology and physiology. Clin Exp Pharmacol Physiol 1991; 18: 379–392
  • Ohlstein E. H., Vickery L., Sauermelch C., Willette R. N. Vasodilation induced by endothelin: role of EDRF and prostanoids in rat hindquarters. Am J Physiol 1990; 259: H1835–H1841
  • Hoffman A., Grossman E., Öhman K. P., Marks E., Keiser H. R. Endothelin induces an initial increase in cardiac output associated with selective vasodilation in rats. Life Sci 1989; 45: 249–255
  • Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Cardiac output effects of endothelin-1, -2 and -3 and sarafotoxin S6b in conscious rats. J Auton Nerv Syst 1990; 30: 143–148
  • Roberts-Thomson P., Minson R. B., McRitchie R. J., Arnolda L. F., Chalmers J. P. Regional haemodynamic effects of neuropeptide Y and endothelin-1 in conscious normotensive and hypertensive rabbits. High Blood Press 1993; 2: 57–65
  • King A., Brenner B. M., Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989; 256: F1051–F1058
  • Knuepfer M. M., Han S. P., Trapani A. J., Fok K. F., Westfall T. C. Regional hemodynamic and baroreflex effects of endothelin in rats. Am J Physiol 1989; 257: H918–H926
  • Le Monnier de Gouville A. C., Mondot S., Lippton H., Hyman A., Cavero I. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats. J Pharmacol Exp Ther 1990; 252: 300–311
  • King A. J., Pfeffer J. M., Pfeffer M. A., Brenner B. M. Systemic hemodynamic effects of endothelin in rats. Am J Physiol 1990; 258: H787–H792
  • Wright C. E., Fozard J. R. Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. Eur J Pharmacol 1988; 155: 201–203
  • Roberts-Thomson P., McRitchie R. J., Chalmers J. P. Endothelin-1 causes a biphasic response in systemic vasculature and increases myocardial contractility in the conscious rabbit. J Cardiovasc Pharmacol 1994; 24: 100–107
  • Le Monnier de Gouville A. C., Cavero I. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin. Br J Pharmacol 1991; 104: 77–84
  • Yanagisawa M. The endothelin system: a new target for therapeutic intervention. Circulation 1994; 89: 1320–1322
  • Gardiner S. M., Compton A. M., Bennett T., Palmer R. M.J., Moncada S. NG-monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur J Pharmacol 1989; 171: 237–240
  • Fozard J. R., Part M. L. The role of nitric oxide in the regional effects of endothelin-1 in the rat. Br J Pharmacol 1992; 105: 744–750
  • Baydoun A. R., Peers S. H., Cirino G., Woodward B. Vasodilator action of endothelin-1 in the perfused rat heart. J Cardiovasc Pharmacol 1990; 15: 759–763
  • Whittle B. J.R., Lopez-Belmonte J., Rees D. D. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol 1989; 98: 646–652
  • White D. G., Mundin J. W., Sumner M. J., Watts I. S. The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture. Br J Pharmacol 1993; 109: 1128–1132
  • Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG -nitro-L-arginine methyl ester. Br J Pharmacol 1990; 101: 632–639
  • Madeddu P., Anania V., Parpaglia P. P., Troffa C., Pazzola A., Soro A., Manunta P., Tonolo G., Demontis M. P., Varoni M. V., Melis M. G., Glorioso N. Endothelin-1-induced renal vasoconstriction is blunted by enalaprilat and enhanced by EDRF antagonist in awake normotensive rats. Clin Invest Med 1991; 14: 600–606
  • Rogerson M. E., Cairns H. S., Fairbanks L. D., Westwick J., Neild G. H. Endothelin-1 in the rabbit: interactions with cyclo-oxygenase and NO-synthase products. Br J Pharmacol 1993; 108: 838–843
  • Télémaque S., Gratton J. P., Claing A., D'Orléans-Juste P. Endothelin-1 induces vasoconstriction and prostacyclin release via the activation of endothelin ETA receptors in the perfused rabbit kidney. Eur J Pharmacol 1993; 237: 275–281
  • Rakugi H., Nakamaru M., Tabuchi Y., Nagano M., Mikami H., Ogihara T. Endothelin stimulates the release of prostacyclin from rat mesenteric arteries. Biochem Biophys Res Commun 1989; 160: 924–928
  • Clozel M., Gray G. A., Breu V., Löffler B. M., Osterwalder R. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992; 186: 867–873
  • Cao L., Banks R. O. Cardiovascular and renal actions of endothelin: effects of calcium-channel blockers. Am J Physiol 1990; 258: F254–F258
  • Madeddu P., Yang X. P., Anania V., Troffa C., Pazzola A., Soro A., Manunta P., Tonolo G., Demontis M. P., Varoni M. V., Melis M. G., Glorioso N. Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin. Am J Physiol 1990; 259: F304–F311
  • Hof R. P., Hof A., Takiguchi Y. Attenuation of endothelin-induced regional vasoconstriction by isradipine: a non-specific antivasoconstrictor effect. J Cardiovasc Pharmacol 1990; 15(Suppl. 1)S48–S48
  • Chabrier P. E., Auguet M., Roubert P., Lonchampt M. O., Gillard V., Guillon J. M., Delaflotte S., Braquet P. Vascular mechanism of action of endothelin-1: effect of Ca2+ antagonists. J Cardiovasc Pharmacol 1989; 13(Suppl. 5)S32–S32
  • Vierhapper H., Wagner O. F., Nowotny P., Waldhäusl W. Effect of endothelin-1 in man: pretreatment with nifedipine, with indomethacin and with cyclosporine A. Eur J Clin Invest 1992; 22: 55–59

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.